Description
Technology commercialization for automotive parts manufacturing
Amendment chain · 3 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $7,009,438 at start, $7,009,438 after amendment #2 (+$0).
- #02017-04-01$7,009,438
- #12021-08-11$7,009,438
- #22024-06-24$7,009,438
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2017-04-01(start date) | $7,009,438 | — | This project supports the transfer of leading edge technologies between a high-cost low-volume high tech indu… |
| #1 amendment | 2021-08-11 | $7,009,438 | +$0 | This project supports the transfer of leading edge technologies between a high-cost low-volume high tech indu… |
| #2 amendment | 2024-06-24 | $7,009,438 | +$0 | Technology commercialization for automotive parts manufacturing |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other recipients funded under "SIF Stream 1- R&D" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2024-2025-Q2-819558 | Coveo Solutions Inc. | FY2025 | $15,170,000 | FY2025 |
| 033-2024-2025-Q2-816194 | Kepler Communications Inc. | FY2025 | $20,000,000 | FY2025 |
| 033-2024-2025-Q2-819803 | Pratt & Whitney Canada Corporation | FY2025 | $11,322,000 | FY2025 |
| 033-2024-2025-Q1-820045 | Biotechnologies Aramis Inc. | FY2025 | $40,000,000 | FY2025 |
| 033-2023-2024-Q3-514239 | Edesa Biotech Research, Inc. | FY2024 | $23,000,000 | FY2024 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2017-2018-Q4-810895 · retrieved 2026-11-12.